Challenges
Escalating Healthcare Costs
Chronic disease drives billions in annual spending. Non-healing conditions require prolonged care and repeated intervention. Costs rise while outcomes often plateau. Current approaches manage symptoms rather than resolve underlying biology.
We develop therapies that intervene at the biological root of disease. Our RNA-enabled nanoparticle platform aims to shorten treatment timelines and reduce reliance on long-term care by restoring active healing.
Strained Clinical Capacity
Community visits and outpatient reviews consume significant NHS resources. Dressing changes and monitoring require ongoing staff time. Treatment pathways remain long. Effective therapies that shorten care duration are limited.
Our locally delivered therapeutics are designed for sustained action at the site of disease. By reducing repeated interventions, we aim to ease pressure on clinical services and support more efficient care delivery.
Patient Burden and Reduced Independence
Chronic conditions disrupt daily life. Patients face persistent discomfort and reduced mobility. Frequent appointments affect work and family life. Mental wellbeing often declines alongside physical health.
We focus on therapies that actively restart repair. By enabling resolution and regeneration, we aim to improve recovery, mobility, and overall quality of life.
Rising Global Disease Prevalence
Ageing populations increase inflammatory and degenerative disease rates. Metabolic disorders add further pressure. Healthcare systems face expanding long-term demand. Innovation must keep pace.
Our platform targets shared immune mechanisms across multiple conditions. This enables expansion beyond single indications and supports scalable treatment strategies for widespread disease burden.